Meeting of the Advisory Committee on Training in Primary Care Medicine and Dentistry, 64585-64586 [2018-27165]

Download as PDF Federal Register / Vol. 83, No. 241 / Monday, December 17, 2018 / Notices and 520 of the FD&C Act (21 U.S.C. 360 and 360j)), and their implementing regulations as well as the provisions of the FD&C Act (sections 531 through 542 of the FD&C Act (21 U.S.C. 360hh through 360ss)) that apply to electronic products, known as the Electronic Product Radiation Control (EPRC) and their implementing regulations. These regulations pertain to the recordkeeping, reporting, manufacturing, importing, and installation of ‘‘electronic products’’ as defined under 21 CFR 1000.3(j). This draft guidance, when finalized, will supersede FDA’s guidance entitled ‘‘Clarification of Radiation Control Regulations for Diagnostic X-Ray Equipment’’ (HHS Publication FDA 89– 8221 issued in March 1989). This draft guidance addresses only the requirements that apply to diagnostic x-ray equipment under the EPRC provisions of the FD&C Act and the regulations implementing those provisions. This draft guidance does not address requirements that may apply to such equipment as medical devices II. Significance of Guidance This draft guidance is being issued consistent with FDA’s good guidance practices regulation (21 CFR 10.115). The draft guidance, when finalized, will represent the current thinking of FDA on ‘‘Clarification of Radiation Control Regulations for Manufacturers of Diagnostic X-Ray Equipment.’’ It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. This guidance is not subject to Executive Order 12866. III. Electronic Access Persons interested in obtaining a copy of the draft guidance may do so by downloading an electronic copy from the internet. A search capability for all Center for Devices and Radiological Health guidance documents is available at https://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/ GuidanceDocuments/default.htm. This guidance document is also available at https://www.regulations.gov. Persons unable to download an electronic copy of ‘‘Clarification of Radiation Control Regulations for Manufacturers of Diagnostic X-Ray Equipment’’ may send an email request to CDRH-Guidance@ fda.hhs.gov to receive an electronic copy of the document. Please use the document number 1500029 to identify the guidance you are requesting. IV. Paperwork Reduction Act of 1995 This draft guidance refers to previously approved collections of information. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501–3520). The collections of information in the following FDA regulations have been approved by OMB as listed in the following table: OMB control No. 21 CFR part Topic 1002, 1005, 1010, 1020, 1030, 1040, and 1050 ....................... Reporting and Recordkeeping for Electronic Products—General Requirements. Dated: December 11, 2018. Leslie Kux, Associate Commissioner for Policy. BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Committee on Training in Primary Care Medicine and Dentistry Health Resources and Service Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Advisory Committee on Training in Primary Care Medicine and Dentistry (ACTPCMD) has scheduled a public meeting. Information about ACTPCMD and the agenda for this meeting can be found on the ACTPCMD website at: https://www.hrsa.gov/ advisory-committees/primarycaredentist/index.html. DATES: January 9, 2019, 9 a.m.–5 p.m. ET, and January 10, 2019, 8:30 a.m.– 2:30 p.m. ET. SUMMARY: VerDate Sep<11>2014 19:17 Dec 14, 2018 Jkt 247001 This meeting will be held in person and will offer virtual access through teleconference and webinar. The address for the meeting is 5600 Fishers Lane, Rockville, Maryland 20857. • Conference call-in number is: 1– 888–455–0640. • Passcode is: HRSA COUNCIL. • Webinar link is: https:// hrsa.connectsolutions.com/actpcmd. FOR FURTHER INFORMATION CONTACT: Kennita Carter, MD, Designated Federal Official (DFO), Division of Medicine and Dentistry, Bureau of Health Workforce, HRSA, 5600 Fishers Lane, 15N–116, Rockville, Maryland 20857; 301–945–3505; or KCarter@hrsa.gov. SUPPLEMENTARY INFORMATION: ACTPCMD provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other matters of significance concerning the activities under section 747 of Title VII of the Public Health Service (PHS) Act, as it existed upon the enactment of Section 749 of the PHS Act in 1998. ACTPCMD prepares an annual report describing the activities of the Committee, including findings and recommendations made by the Committee concerning the activities under section 747, as well as training ADDRESSES: [FR Doc. 2018–27236 Filed 12–14–18; 8:45 am] amozie on DSK3GDR082PROD with NOTICES1 under provisions of the FD&C Act and its implementing regulations. PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 64585 0910–0025 programs in oral health and dentistry. The annual report is submitted to the Secretary and Chairman and ranking members of the Senate Committee on Health, Education, Labor and Pensions, and the House of Representatives Committee on Energy and Commerce. The Committee is also charged with developing, publishing, and implementing performance measures and guidelines for longitudinal evaluations of programs authorized under Title VII, part C of the PHS Act, and recommending appropriation levels for programs under this part. During the January 9–10, 2019, meeting, ACTPCMD will discuss innovations in primary care and oral health training. Agenda items are subject to change as priorities dictate. Refer to the ACTPCMD website for any updated information concerning the meeting. The meeting agenda will be available on the ACTPCMD website at least 14 days prior to the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or submit a written statement to ACTPCMD should be sent to Kennita E:\FR\FM\17DEN1.SGM 17DEN1 64586 Federal Register / Vol. 83, No. 241 / Monday, December 17, 2018 / Notices Carter, DFO, using the contact information above at least 3 business days prior to the meeting. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Kennita Carter at the address and phone number listed above at least 10 business days prior to the meeting. Since this meeting occurs in a federal government building, attendees must go through a security check to enter the building. Non-U.S. Citizen attendees must notify HRSA of their planned attendance at least 10 business days prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–27165 Filed 12–14–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome Research Institute; Notice of Closed Meeting amozie on DSK3GDR082PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Inherited Disease Research Access Committee. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Inherited Disease Research Access Committee. Date: January 11, 2019. Time: 11:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, Suite 3100, Room 3185, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Barbara J. Thomas, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, National Institutes of Health, 5635 Fishers Lane, Ste. 4076, MSC 9306, Bethesda, MD 20892–9306, 301–402–0838, barbara.thomas@nih.gov. VerDate Sep<11>2014 19:17 Dec 14, 2018 Jkt 247001 (Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS) Dated: December 11, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–27179 Filed 12–14–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; ‘‘2019 Beeson Review’’. Date: January 17–18, 2019. Time: 4:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Garden Inn, 7301 Waverly St., Bethesda, MD 20892. Contact Person: Alexander Parsadanian, Ph.D., Scientific Review Officer, National Institute on Aging, Gateway Building 2c/212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–496–9666, PARSADANIANA@ NIA.NIH.GOV. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: December 11, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–27180 Filed 12–14–18; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7001–N–60] 30-Day Notice of Proposed Information Collection: Builder’s Certification of Plans, Specifications and Site Office of the Chief Information Officer, HUD. ACTION: Notice. AGENCY: HUD submitted the proposed information collection requirement described below to the Office of Management and Budget (OMB) for review, in accordance with the Paperwork Reduction Act. The purpose of this notice is to allow for 30 days of public comment. DATES: Comments Due Date: January 16, 2019. ADDRESSES: Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB Control Number and should be sent to: HUD Desk Officer, Office of Management and Budget, New Executive Office Building, Washington, DC 20503; fax: 202–395–5806, Email: OIRA Submission@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: Colette Pollard, Reports Management Officer, QMAC, Department of Housing and Urban Development, 451 7th Street SW, Washington, DC 20410; email Colette.Pollard@hud.gov, or telephone 202–402–3400. This is not a toll-free number. Person with hearing or speech impairments may access this number through TTY by calling the toll-free Federal Relay Service at (800) 877–8339. Copies of available documents submitted to OMB may be obtained from Ms. Pollard. SUPPLEMENTARY INFORMATION: This notice informs the public that HUD is seeking approval from OMB for the information collection described in Section A. The Federal Register notice that solicited public comment on the information collection for a period of 60 days was published on August 21, 2018 at 83 FR 42312. SUMMARY: A. Overview of Information Collection Title of Information Collection: Builder’s Certification of Plans, Specifications, and Site. OMB Approved Number: 2502–0496. Type of Request: Revision. Form Number: HUD–92541. Description of the need for the information and proposed use: Builders use the form to certify that a property does not have adverse conditions and is not located in a special flood hazard E:\FR\FM\17DEN1.SGM 17DEN1

Agencies

[Federal Register Volume 83, Number 241 (Monday, December 17, 2018)]
[Notices]
[Pages 64585-64586]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27165]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Training in Primary Care 
Medicine and Dentistry

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Advisory Committee on Training in Primary Care Medicine 
and Dentistry (ACTPCMD) has scheduled a public meeting. Information 
about ACTPCMD and the agenda for this meeting can be found on the 
ACTPCMD website at: https://www.hrsa.gov/advisory-committees/primarycare-dentist/index.html.

DATES: January 9, 2019, 9 a.m.-5 p.m. ET, and January 10, 2019, 8:30 
a.m.-2:30 p.m. ET.

ADDRESSES: This meeting will be held in person and will offer virtual 
access through teleconference and webinar. The address for the meeting 
is 5600 Fishers Lane, Rockville, Maryland 20857.
     Conference call-in number is: 1-888-455-0640.
     Passcode is: HRSA COUNCIL.
     Webinar link is: https://hrsa.connectsolutions.com/actpcmd.

FOR FURTHER INFORMATION CONTACT: Kennita Carter, MD, Designated Federal 
Official (DFO), Division of Medicine and Dentistry, Bureau of Health 
Workforce, HRSA, 5600 Fishers Lane, 15N-116, Rockville, Maryland 20857; 
301-945-3505; or KCarter@hrsa.gov.

SUPPLEMENTARY INFORMATION: ACTPCMD provides advice and recommendations 
to the Secretary of HHS (Secretary) on policy, program development, and 
other matters of significance concerning the activities under section 
747 of Title VII of the Public Health Service (PHS) Act, as it existed 
upon the enactment of Section 749 of the PHS Act in 1998. ACTPCMD 
prepares an annual report describing the activities of the Committee, 
including findings and recommendations made by the Committee concerning 
the activities under section 747, as well as training programs in oral 
health and dentistry. The annual report is submitted to the Secretary 
and Chairman and ranking members of the Senate Committee on Health, 
Education, Labor and Pensions, and the House of Representatives 
Committee on Energy and Commerce. The Committee is also charged with 
developing, publishing, and implementing performance measures and 
guidelines for longitudinal evaluations of programs authorized under 
Title VII, part C of the PHS Act, and recommending appropriation levels 
for programs under this part. During the January 9-10, 2019, meeting, 
ACTPCMD will discuss innovations in primary care and oral health 
training. Agenda items are subject to change as priorities dictate. 
Refer to the ACTPCMD website for any updated information concerning the 
meeting. The meeting agenda will be available on the ACTPCMD website at 
least 14 days prior to the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to make 
oral comments or submit a written statement to ACTPCMD should be sent 
to Kennita

[[Page 64586]]

Carter, DFO, using the contact information above at least 3 business 
days prior to the meeting.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Kennita Carter at the 
address and phone number listed above at least 10 business days prior 
to the meeting. Since this meeting occurs in a federal government 
building, attendees must go through a security check to enter the 
building. Non-U.S. Citizen attendees must notify HRSA of their planned 
attendance at least 10 business days prior to the meeting in order to 
facilitate their entry into the building. All attendees are required to 
present government-issued identification prior to entry.

Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-27165 Filed 12-14-18; 8:45 am]
 BILLING CODE 4165-15-P